ADLM offers ACCENT® continuing education credit to laboratory professionals to document their continuing education and meet requirements for licensure or certification. This educational activity is designated for a maximum of 6.0 ACCENT credits. Learners should claim only the credit commensurate with the extent of their participation in the activity.
ADLM is an approved provider of continuing education for clinical laboratory professionals in many global agencies and several US states including California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, and West Virginia. California clinical laboratory professionals requesting ACCENT credit must provide their license number for credit to be reported to the California Department of Public Health Laboratory Field Services. Florida clinical laboratory professionals requesting ACCENT credit must provide their license number for credit to be reported to CE Broker.
ADLM is also accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This educational activity is designated for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As a provider of continuing education, ADLM has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of ADLM’s Annual Meeting Organizing Committee (AMOC).
The faculty, planning committee members, and staff who are in a position to control the content of this activity are required to disclose to ADLM and to learners any financial relationship(s) of the individual that have occurred within the last 24 months with any ACCENT-defined commercial interests or ACCME-defined ineligible companies and. A commercial interest or ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are defined by remuneration in any amount from the commercial interest or ineligible company in the form of honoraria; consulting fees; grants or research support; payments for participation in advisory boards, boards of directors, committees, or speakers’ bureaus; stocks, bonds, other ownership interests; salary; intellectual property or royalties; or other financial benefits.
The intent of this disclosure is not to prevent planners with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity regarding exposition or conclusion. ADLM has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.
The following faculty, planning committee, and content reviewers reported the following financial relationships:
The following faculty reported no financial relationships:
Baha Adam, Darci Block, Patrick Bossuyt, Sarah Braswell, Olivia Braswell, Saswati Das, Meghan Delaney, Shu-Ling Fan, Aaron Geno, Jonathan Genzen, Geoff Hollett, Patricia Jones, Edward Leung, Jieli Shirley Li, Christina Lockwood, Thomas Lorey, Edmunds Reineks, Matthew Shashack, Joely Straseski, Clayton Wilburn, Gabrielle Winston-McPherson
ADLM staff involved in the planning of this activity reported no financial relationships.
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; and/or all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of ADLM.
Use of Professional Judgment
The educational content in this activity relates to basic principles of clinical laboratory medicine and does not substitute for individual assessment based on the health care professional’s examination of the patient, laboratory data, and other factors unique to the patient. Standards in medicine change as new data becomes available.
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.
The association has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The association requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.
The association will record learner’s personal information as provided on continuing education evaluations to allow for issuance and tracking of CE certificates. The association may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its continuing education program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.
This activity is not supported by educational grant(s) or other funds from any commercial supporter(s).
You must be registered for activity to be eligible to earn continuing education credit (ACCENT or AMA PRA Category 1 Credit™). Continuing education certificates are provided to registered participants based on completion of the activity, in its entirety, including the activity evaluation.
Participants are not able to claim continuing education credit for this activity after December 31, 2027.
